1. Home
  2. VIOT vs VERU Comparison

VIOT vs VERU Comparison

Compare VIOT & VERU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Viomi Technology Co. Ltd

VIOT

Viomi Technology Co. Ltd

HOLD

Current Price

$0.70

Market Cap

53.9M

ML Signal

HOLD

Logo Veru Inc.

VERU

Veru Inc.

HOLD

Current Price

$2.73

Market Cap

48.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VIOT
VERU
Founded
2014
1971
Country
China
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Appliances
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
53.9M
48.2M
IPO Year
2018
1996

Fundamental Metrics

Financial Performance
Metric
VIOT
VERU
Price
$0.70
$2.73
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$22.50
AVG Volume (30 Days)
69.2K
273.5K
Earning Date
03-25-2026
05-12-2026
Dividend Yield
13.49%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$16,296,958.00
Revenue This Year
N/A
N/A
Revenue Next Year
$9.04
N/A
P/E Ratio
$3.56
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.71
$2.05
52 Week High
$3.86
$7.33

Technical Indicators

Market Signals
Indicator
VIOT
VERU
Relative Strength Index (RSI) 30.56 60.04
Support Level N/A $2.12
Resistance Level $0.94 $2.85
Average True Range (ATR) 0.03 0.14
MACD -0.00 0.07
Stochastic Oscillator 0.00 79.45

Price Performance

Historical Comparison
VIOT
VERU

About VIOT Viomi Technology Co. Ltd

Viomi Technology Co Ltd, along with its subsidiaries, specializes in the development and sale of Internet-of-Things-enabled smart home products, particularly focusing on home water solutions. The company markets its products in China and generates the majority of its revenue through the sale of smart water purification systems and other connected home devices designed to improve convenience and automation in residential settings. Its product offerings include water purification products, water heaters, smart water kettles, electric kettles, water filters, range hoods, gas stoves, and other small appliances.

About VERU Veru Inc.

Veru Inc is a late clinical-stage biopharmaceutical focused on developing medicines for the treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabulin. Enobosarm, an oral selective androgen receptor modulator, is being developed to make weight reduction by GLP-1 RA drugs more tissue selective for loss of fat and preservation of lean mass, and is planned for a Phase 2b PLATEAU clinical study in obesity. Sabizabulin, an oral microtubule disruptor, is being developed for the treatment of inflammation in atherosclerotic cardiovascular disease to lower high-sensitivity CRP in patients with stable coronary artery disease, with a planned Phase 2 study.

Share on Social Networks: